The global immunoassay market size accounted for USD 18,626.7 million in 2018 and is projected to register a CAGR of 5.9% over the forecast period. Immunoassay is a biochemical test that relies on biochemistry to measure the presence and concentration of an analyte (protein, lipid, nucleic acid, among others) in solution (serum, urine, etc.) by using antibody-antigen reactions. Some of the factors characterizing the market growth are rising R&D expenditure in the healthcare sector, rising prevalence of chronic and infectious diseases, increasing adoption of immunoassay, technological advancements in immunoassay instruments and the introduction of novel automated systems, and surging elderly population across the world. For instance, the World Health Organization (WHO) reported that global elderly population was 841.0 million in 2013, increased to 962.
The blood glucose monitoring market is one of the rapidly growing markets across the world owing to huge growth in urbanization leading to the increased incidence of obesity, unhealthy diet, and physical inactiveness, which has increased the diabetic population around the globe. Regular monitoring of glucose level is important to avoid further complications. Furthermore, invention of new technology, increasing awareness, investment in research and development have boosted the blood glucose monitoring market globally. However, high cost associated with monitoring and diagnosis of disease may restrain the market growth.
The global blood glucose monitoring market is expected to grow at a CAGR of 7.1% during forecasted period 2017-2023.
The Chemotherapy Market is estimated to be valued at USD 56,491.59 Million by 2024 and is expected to register a CAGR of 11.50% during the forecast period.
The alkylating agents segment dominated the global chemotherapy market, by drug class, and is projected to reach USD 20,360.32 Million by 2024 and projected to be the fastest-growing segment during the forecast period.
Americas dominated the market, accounting for the largest share of the market in 2018, and the regional market is expected to register a CAGR of 10.88% during the review period. The European market was the second largest in 2018. The market is projected to reach USD 18,292.73 Million by the end
The global preclinical imaging market is anticipated to have held a value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging.
Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to
Global cancer immunotherapy market is expecting growth at a very high rate in the coming future. This is due to the increasing number of patients suffering from different types of cancer. Globally approximately 100 types of different types of cancer have been registered. And in terms of treatment, limited number of treatments are available in the market. Cancer immunotherapy is expecting to make a huge development in coming future due to its various advantages. Immunotherapy is more effective than other available therapies and have lesser side effects. Increasing cancer population across the globe is a direct consequence of the lowering health standards i.e. increasing smoking and alcohol intake in millennial population has led to an increase in the number of lung and liver cancers. Which has provided a fuel for the development of the market. Lo
An insightful report furnished by Market Research Future (MRFR) suggests that the Asia Pacific (APAC) Aesthetics Market is poised to grow at an approximate growth rate of 11.50% during the forecast period (2017-2023).
Market Drivers and Key Barriers
The increasing expenditure on cosmetic surgeries is expected to be the primary factor backing the market growth. The International Trade Administration had stated in 2015 that the per capita cosmetic expenditure had reached the valuation of USD 174 in Japan that year. Additionally, as per estimations, the countries in Asia receive huge exports from the United States (U.S) for the given reason. Other than this, the growing prevalence of skin diseases such as actinic keratosis a
Orthopedic implants market is experiencing a surge in sale across the globe, and it has been considerably boosted by technological advancement. The global orthopedic implants market can expect a 6.8% CAGR during the forecast period (2017-2023), reveals Market Research Future (MRFR) in a detailed study. The study includes orthopedic implants market drivers such as increasing prevalence of orthopedic conditions such as fractures, osteoporosis, arthritis and technological advancement which has led to the use of more sophisticated implants. Obesity, sedentary lifestyle and adventure sports are instigating such diseases. Furthermore, governments are also investing much in research and developments that are helping the market gain momentum. At the same time, developing countries are opening up wide spaces for orthopedic implants market to expand.
The global dental prosthetics market, during the forecast period 2018 to 2023, will register growth at a CAGR of 5.5%. The market for dental prosthetics is set to reach US$5.65 billion by 2023. As per dental prosthetics market analysts, the global market is anticipated to witness growth owing to the factors such as rising acceptance of evidence-based dentistry as well as growing adoption of CAD/CAM technology. However, the dental prosthetics market will face challenges and restraints due to slow introduction of advanced technologies and high degree of discrepancy in the cost during the forecast period 2018 to 2023.
The rising cases of dental caries and tooth loss in the dental prosthetics market is set to play a key role in determining the growth potential during 2018 to 2023 years. Analysts have also studied the dental prosthetics market to
Cosmetic dentistry is the dental work that helps improve the look of a person’s teeth. The treatment includes teeth whitening, straightening, reshaping, and realignment. There are several other cosmetic dental services, which include cosmetic gum surgery, tooth contouring and reshaping, tooth colored fillings, composite bonding, dental implants, and inlays and onlays. Technological advancements have also allowed the application of novel techniques.
The high cost of dental imaging procedures and lack of reimbursement options hinder the growth of this market.
The global cosmetic dentistry market is dominated by many key market players. These players are engaged in new product launches and tactical partnerships to brace their market position. For instance, in April 2017, Zimmer Biomet Holdings, Inc. announced the distribution of NovaBone Dental Putty in over 40 countries within the M
The global healthcare chatbots market is estimated to garner nearly USD 543.65 million by 2026, states Market Research Future (MRFR) in its latest report. It can experience 19.5% CAGR over the forecast period (2018-2023) owing to the adoption of automated processes to alleviate workflow in the healthcare sector.
Rising number of healthcare mobile applications users is expected to drive the market demand exponentially till 2023. According to the survey by HIMSS Mobile Technology Survey in 2015, nearly 180 healthcare providers engage patients via mobile apps. This has also been approved by doctors and hospitals. In addition, rising prevalence of chronic diseases is expected to induce the need for chatbots which can fetch health-related data of patients and assist with rapid diagnosis. Cancer patients and their caregivers increasingly rely on